Schedule 13G ownership disclosure

LUMOS PHARMA INC

Security class unavailable · CUSIP: 55028X109

Event date: 2022-01-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
496,811
Percent of class
5.9400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001062993-22-002189
Form type
SC 13G/A
Filer
Farb Daniel Stuart
CIK
CIK 1776353
Filed
Feb 02, 2022
Reporting period
Jan 27, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub